MedTrace Logo

Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

NCT02245997 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2025-09-29

No results posted yet for this study

Summary

The purpose of this study is to give 12T a smaller dose of radiation in order to decrease these late side effects.

Conditions

Interventions

RADIATION

External beam radiotherapy

RADIATION

proton beam RT

Sponsors & Collaborators

Principal Investigators

  • Suzanne Wolden, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2025-05-01
Completion
2025-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02245997 on ClinicalTrials.gov